genetics experience summary nr.110.521a- cns ii july, 2013 tania randell, rn-bc, bsn
TRANSCRIPT
Genetics Experience
Summary
NR.110.521A- CNS IIJuly, 2013Tania Randell, RN-BC, BSN
Location & Focus
Johns Hopkins Outpatient Center Cardiology Clinic
Genetic Counselor sees patients with various types of structural Cardiomyopathy (CM)
ARVD Dilated Hypertrophic Restrictive Non-compaction Amyloid
Typical Patients
Patients are referred by their Cardiologist who specializes in Cardiomyopathy
Genetic counselor works for this physician
If interested- Initial phone call Pedigree is done by email Initial interview & description of testing If patient agrees to Pan CM Panel, they return for
explanation of results
Case Study
34 y/o AA Female diagnosed w/ Dilated CM @ 29
Pregnant with twins (induce 12 wks early)
10 siblings, Sister w/ CM
Other relatives- disease processes and deaths that are now questionable (strokes, “accident”)
Babies have 50% chance of developing CM
Testing only 20-30% chance of getting a definitive explanation for the CM
Implications for APNs
Baseline knowledge of genetic testing
Referral information
Who is appropriate for referral
Collaborate w/ MDs
Insights…
Races other than Caucasian and African American have a small pool (need more participants-what’s normal for their group)
Even when mutations are identified, only handful of results change treatment (ICD, frequent Echoes)
Most people do testing to help their families
Families w/ a great deal of disease are best to study (can find links between their genes)
Return yearly (science is developing rapidly)
Reference
Baxter S., Cirino, A, Funke, B., Ho, C., Hernandez A.L., Rehm,H., Seidman, C., & Seidman, J. (2013). Genetic Basis of Cardiomyopathy: A Guide for Patients and Families. Harvard Medical School Laboratory for Molecular Medicine, Cambridge, MA.